Despite underperforming the market over the past year, Medtronic still enjoys fairly upbeat outlook from analysts.

Medtronic (NYSE: MDT) announced that Gregory L. Smith, EVP, enterprise operations, notified the company of his decision to ...

A Medtronic hypertension procedure that can provide last-resort treatment for a condition that affects nearly half of all U.S ...

The pharma company's newer immunology drugs, Skyrizi and Rinvoq, have delivered robust sales growth that's proving to be the ...

Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment ...

With a market cap of $120.1 billion, Medtronic plc (MDT) is a global leader in healthcare technology, transforming lives ...

Medtronic today announced the launch of its Stedi extra support guidewire for use with its Evolut TAVR platform.

The Minnesota medtech company’s Altaviva implant just secured FDA approval. It treats urinary urge incontinence, a ...

Intuitive Surgical (ISRG 0.81%) has dominated the market for robotic-assisted surgery (RAS) devices for the better part of ...

National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained ...

Press Release  Medical technology leader, Medtronic has successfully concluded the UK leg of its European ACM2U Truck ...

Medtronic has initiated the Embrace Gynecology study in the US to assess the Hugo robotic-assisted surgery (RAS) system's ...